Clinical and Translational Epidemiology
The Clinical and Translational Epidemiology Branch in NCI’s Epidemiology and Genomics Research Program stimulates, promotes, and supports cancer epidemiologic research to identify clinical, genomic, and lifestyle factors that improve outcomes for cancer survivors.
We also support research that examines factors associated with cancer development among individuals with underlying diseases and conditions.
Research areas of interest include:
- cancer survivor research
- adverse events and late effects
- diet/lifestyle factors
- predictive, prognostic and genomic factors
- pharmacoepidemiology and pharmacogenomics
- clinical epidemiology and risk prediction
Learn More About
Interest Areas
Learn more about CTEB’s interests in the following areas, relevant funding opportunity announcements, related EGRP events, and staff contacts.